You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer

Authors

  1. Correspondence to Dr Yoku Hayakawa, Department of Gastroenterology, Graduate school of medicine, the University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; yhayakawa-tky{at}umin.ac.jp; Dr Ryota Niikura, Department of Gastroenterology, Graduate school of medicine, the University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; niikura-dky{at}umin.ac.jp
View Full Text

Citation

Arai J, Niikura R, Hayakawa Y, et al
OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer
Gut 2022;71:1043-1044.

Publication history

  • Received July 2, 2021
  • Accepted July 11, 2021
  • First published August 3, 2021.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.